PharmaResearch Co., Ltd. (KOSDAQ:214450)

South Korea flag South Korea · Delayed Price · Currency is KRW
326,500
+1,500 (0.46%)
Apr 29, 2026, 10:10 AM KST
-13.05%
Market Cap 3.38T
Revenue (ttm) 536.29B
Net Income (ttm) 165.12B
Shares Out 10.39M
EPS (ttm) 14,932.75
PE Ratio 21.76
Forward PE 16.77
Dividend 3,700.00 (1.11%)
Ex-Dividend Date Dec 29, 2025
Volume 27,418
Average Volume 68,562
Open 331,000
Previous Close 325,000
Day's Range 325,000 - 336,500
52-Week Range 278,500 - 713,000
Beta 0.62
RSI 56.57
Earnings Date May 8, 2026

About PharmaResearch

PharmaResearch Co., Ltd., together with its subsidiaries, operates as a biopharmaceutical company primarily in South Korea. The company offers Re-An eye drops for protecting eyes from corneal damages with various causes; JBP PLAMON injection, a brown ampoule containing a pale yellow transparent liquid; ZADAXIN injection, an adjunctive therapy for influenza vaccination in immunocompromised elderly patients; PLACENTEX injection for the treatment and tissue restoration of wounds; CLEVIEL VOLUME to temporarily improve facial wrinkles in adults thro... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1993
Employees 497
Stock Exchange KOSDAQ
Ticker Symbol 214450
Full Company Profile

Financial Performance

In 2025, PharmaResearch's revenue was 536.29 billion, an increase of 53.18% compared to the previous year's 350.12 billion. Earnings were 165.12 billion, an increase of 79.39%.

Financial Statements

News

There is no news available yet.